Oleksandr Kachanov, MD | |
105 S State St, Ste 113, Aberdeen, SD 57401-4501 | |
(605) 225-0378 | |
(605) 225-7919 |
Full Name | Oleksandr Kachanov |
---|---|
Gender | Male |
Speciality | Pediatrics - Pediatric Critical Care Medicine |
Location | 105 S State St, Aberdeen, South Dakota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629345723 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Oleksandr Kachanov, MD Po Box 1460, Aberdeen, SD 57402-1460 Ph: (605) 225-0378 | Oleksandr Kachanov, MD 105 S State St, Ste 113, Aberdeen, SD 57401-4501 Ph: (605) 225-0378 |
News Archive
Johnson & Johnson and Elan Corporation plc today announced that JANSSEN Alzheimer Immunotherapy, a newly formed subsidiary of Johnson & Johnson, has completed the acquisition of substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP).
Scientists in California are reporting development of a new generation of the microcapsules used in carbon-free copy paper, in which capsules burst and release ink with pressure from a pen. The new microcapsules burst when exposed to light, releasing their contents in ways that could have wide-ranging commercial uses from home and personal care to medicine. Their study appears in the Journal of the American Chemical Society, a weekly publication.
What's the point of setting up marine reserves to protect coral reefs from pollution, ship groundings and overfishing if climate change could cause far more damage? A study published this week in London in Proceedings of the Royal Society B provides the answer.
Results of a UK study published online suggest that the widely practised approach of isolating intensive-care patients infected with MRSA does not reduce cross-infection. Authors of the study caution that this finding should not be extended to general hospital wards, and needs further confirmation from larger studies.
Chelsea Therapeutics International, Ltd. reported findings from Study 305, a study evaluating the effect of Northeraâ„¢ (Droxidopa), an investigational agent being studied for the treatment of neurogenic orthostatic hypotension (NOH), on patients' 24-hour blood pressure (BP) profile.
› Verified 6 days ago
Dr. Georgia Santos-jawaid, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 201 S Lloyd St, Suite E205, Aberdeen, SD 57401 Phone: 605-622-4050 Fax: 605-622-4049 | |
Dr. Juan R Chavier, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1440 15th Ave Nw, Aberdeen, SD 57401 Phone: 605-725-1700 Fax: 605-725-1761 |